Canigen Rabies

Target species: Dogs and cats. Indications for use: For the active immunisation against rabies to reduce clinical signs and mortality. Onset of immunity: an adequate serological response (≥ 0.5 I.U.) has been demonstrated 2 to 3 weeks after vaccination. Duration of immunity: 3 years. Contraindications: Do not use in unhealthy animals. The vaccine may not be effective in animals incubating the disease at the time of vaccination. Some animals may be immunologically incompetent and fail to respond to vaccination (see further information). Animals that have received the corresponding anti-serum or immunosuppressive drugs should not be vaccinated until an interval of at least 4 weeks has elapsed. Special warnings for each target species:None Special precautions for use, including special precautions to be taken by the person administering the medicinal product to animals Special precautions for use in animals: The presence of maternal antibodies can interfere with the response to vaccination. Special precautions to be taken by the person administering the medicinal product to animals : None Adverse Reactions (frequency and seriousness): Transient local reactions such as non-painful diffuse to firm swellings of approximately 1 cm in diameter may be observed for up to 3 weeks after subcutaneous vaccination. In the rare event of a hypersensitivity reaction following vaccination, administer an antihistamine, corticosteroid or adrenaline, without delay and by the most immediate route. Use during pregnancy and lactation: Can be used during pregnancy in dogs. There are no laboratory data on use during pregnancy in other species, but on basis of field experience, such use is expected to be safe. Interactions with other medicinal products and other forms of interaction: Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with vaccines of the Canigen range containing one or more of the following: live canine distemper, canine adenovirus, canine parvovirus and canine parainfluenza and inactivated canine leptospirosis antigens Leptospira canicola and icterohaemorrhagiae or live feline viral rhinotracheitis virus, feline calicivirus and feline panleucopenia virus. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. This product should not be given for at least one month following the administration of hyperimmune serum or immunosuppressant drugs.
Vat Rate: 20%